313 related articles for article (PubMed ID: 14673169)
21. Brg1 Enables Rapid Growth of the Early Embryo by Suppressing Genes That Regulate Apoptosis and Cell Growth Arrest.
Singh AP; Foley JF; Rubino M; Boyle MC; Tandon A; Shah R; Archer TK
Mol Cell Biol; 2016 Aug; 36(15):1990-2010. PubMed ID: 27185875
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
23. De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins.
Squillaro T; Severino V; Alessio N; Farina A; Di Bernardo G; Cipollaro M; Peluso G; Chambery A; Galderisi U
Cell Cycle; 2015; 14(8):1315-26. PubMed ID: 25724006
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells.
Wang X; Gong Y; Jin B; Wu C; Yang J; Wang L; Zhang Z; Mao Z
Oncol Rep; 2014 Sep; 32(3):1281-90. PubMed ID: 24993775
[TBL] [Abstract][Full Text] [Related]
25. Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway.
Wang G; Fu Y; Hu F; Lan J; Xu F; Yang X; Luo X; Wang J; Hu J
Cell Death Dis; 2017 Feb; 8(2):e2607. PubMed ID: 28182012
[TBL] [Abstract][Full Text] [Related]
26. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
27. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
28. Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.
Law BK; Chytil A; Dumont N; Hamilton EG; Waltner-Law ME; Aakre ME; Covington C; Moses HL
Mol Cell Biol; 2002 Dec; 22(23):8184-98. PubMed ID: 12417722
[TBL] [Abstract][Full Text] [Related]
29. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
30. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
Lepley DM; Pelling JC
Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
[TBL] [Abstract][Full Text] [Related]
31. Brg1-dependent epigenetic control of vascular smooth muscle cell proliferation by hydrogen sulfide.
Li L; Liu D; Bu D; Chen S; Wu J; Tang C; Du J; Jin H
Biochim Biophys Acta; 2013 Jun; 1833(6):1347-55. PubMed ID: 23499876
[TBL] [Abstract][Full Text] [Related]
32. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
Wang L; Baiocchi RA; Pal S; Mosialos G; Caligiuri M; Sif S
Mol Cell Biol; 2005 Sep; 25(18):7953-65. PubMed ID: 16135788
[TBL] [Abstract][Full Text] [Related]
33. Mutant p53 can delay growth arrest and loss of CDK2 activity in senescing human fibroblasts without reducing p21(WAF1) expression.
Wyllie F; Haughton M; Bartek J; Rowson J; Wynford-Thomas D
Exp Cell Res; 2003 May; 285(2):236-42. PubMed ID: 12706118
[TBL] [Abstract][Full Text] [Related]
34. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
[TBL] [Abstract][Full Text] [Related]
36. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
Green SL; Freiberg RA; Giaccia AJ
Mol Cell Biol; 2001 Feb; 21(4):1196-206. PubMed ID: 11158306
[TBL] [Abstract][Full Text] [Related]
37. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
38. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
39. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex.
de la Serna IL; Ohkawa Y; Berkes CA; Bergstrom DA; Dacwag CS; Tapscott SJ; Imbalzano AN
Mol Cell Biol; 2005 May; 25(10):3997-4009. PubMed ID: 15870273
[TBL] [Abstract][Full Text] [Related]
40. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.
Yun J; Chae HD; Choi TS; Kim EH; Bang YJ; Chung J; Choi KS; Mantovani R; Shin DY
J Biol Chem; 2003 Sep; 278(38):36966-72. PubMed ID: 12857729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
